These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 1369787

  • 1. [The cost of arterial hypertension in Spain].
    Badía X, Rovira J, Tresserras R, Trinxet C, Segú JL, Pardell H.
    Med Clin (Barc); 1992 Dec 12; 99(20):769-73. PubMed ID: 1369787
    [Abstract] [Full Text] [Related]

  • 2. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD, Gillett M, Holmes M, Ogden E.
    Public Health; 2006 Dec 12; 120(12):1140-8. PubMed ID: 17084425
    [Abstract] [Full Text] [Related]

  • 3. The cost of obesity in Canada.
    Birmingham CL, Muller JL, Palepu A, Spinelli JJ, Anis AH.
    CMAJ; 1999 Feb 23; 160(4):483-8. PubMed ID: 10081464
    [Abstract] [Full Text] [Related]

  • 4. An economic evaluation of a perindopril-based blood pressure lowering regimen for patients who have suffered a cerebrovascular event.
    Tavakoli M, Pumford N, Woodward M, Doney A, Chalmers J, MacMahon S, Macwalter R.
    Eur J Health Econ; 2009 Feb 23; 10(1):111-9. PubMed ID: 18446392
    [Abstract] [Full Text] [Related]

  • 5. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
    Huse DM, Song X, Ozminkowski RJ, Maguire J, Williams SA, Borok GM, McDonough K.
    Clin Ther; 2006 Sep 23; 28(9):1425-42. PubMed ID: 17062315
    [Abstract] [Full Text] [Related]

  • 6. Socio-economic cost and health-related quality of life of burn victims in Spain.
    Sanchez JL, Bastida JL, Martínez MM, Moreno JM, Chamorro JJ.
    Burns; 2008 Nov 23; 34(7):975-81. PubMed ID: 18472221
    [Abstract] [Full Text] [Related]

  • 7. The socioeconomic costs of mental illness in Spain.
    Oliva-Moreno J, López-Bastida J, Montejo-González AL, Osuna-Guerrero R, Duque-González B.
    Eur J Health Econ; 2009 Oct 23; 10(4):361-9. PubMed ID: 19031056
    [Abstract] [Full Text] [Related]

  • 8. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000 Oct 23; 74(3):215-53. PubMed ID: 10918811
    [Abstract] [Full Text] [Related]

  • 9. The impact of prevention on reducing the burden of cardiovascular disease.
    Kahn R, Robertson RM, Smith R, Eddy D.
    Circulation; 2008 Jul 29; 118(5):576-85. PubMed ID: 18606915
    [Abstract] [Full Text] [Related]

  • 10. Economic evaluation of varicella vaccination in Spain: results from a dynamic model.
    Lenne X, Diez Domingo J, Gil A, Ridao M, Lluch JA, Dervaux B.
    Vaccine; 2006 Nov 17; 24(47-48):6980-9. PubMed ID: 16860909
    [Abstract] [Full Text] [Related]

  • 11. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain.
    Lopez-Bastida J, Serrano-Aguilar P, Perestelo-Perez L, Oliva-Moreno J.
    Neurology; 2006 Dec 26; 67(12):2186-91. PubMed ID: 17190942
    [Abstract] [Full Text] [Related]

  • 12. [Costs of known diabetes mellitus in Spain].
    Hart WM, Espinosa C, Rovira J.
    Med Clin (Barc); 1997 Sep 13; 109(8):289-93. PubMed ID: 9379750
    [Abstract] [Full Text] [Related]

  • 13. Cost of hypertension in Spain.
    Rovira J, Badia X, Pardell H.
    J Hum Hypertens; 1992 Dec 13; 6(6):481-3. PubMed ID: 1296013
    [No Abstract] [Full Text] [Related]

  • 14. [The calculation of AIDS costs in Spain by simulation technics].
    Antoñanzas Villar F, Antón Botella F, Juárez Castello C.
    Med Clin (Barc); 1995 Apr 22; 104(15):568-72. PubMed ID: 7769865
    [Abstract] [Full Text] [Related]

  • 15. [Epidemiologic evaluation of cardiac decompensation and its impact on health costs].
    Bilora F, Vettore G, Saccaro G, Barbata A, Dei Rossi C, Petrobelli F.
    Minerva Cardioangiol; 1998 Apr 22; 46(7-8):235-9. PubMed ID: 9973786
    [Abstract] [Full Text] [Related]

  • 16. The economic impact of the introduction of home blood pressure measurement for the diagnosis and treatment of hypertension.
    Funahashi J, Ohkubo T, Fukunaga H, Kikuya M, Takada N, Asayama K, Metoki H, Obara T, Inoue R, Hashimoto J, Totsune K, Kobayashi M, Imai Y.
    Blood Press Monit; 2006 Oct 22; 11(5):257-67. PubMed ID: 16932035
    [Abstract] [Full Text] [Related]

  • 17. Lifestyle modifications to prevent and control hypertension. 3. Recommendations on alcohol consumption. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Campbell NR, Ashley MJ, Carruthers SG, Lacourcière Y, McKay DW.
    CMAJ; 1999 May 04; 160(9 Suppl):S13-20. PubMed ID: 10333849
    [Abstract] [Full Text] [Related]

  • 18. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J, Zoellner Y, Gradl B, Palache B, Medema J.
    Vaccine; 2006 Nov 17; 24(47-48):6812-22. PubMed ID: 17034909
    [Abstract] [Full Text] [Related]

  • 19. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX, Ye X, Lee KY, Dupclay L, Plauschinat C.
    Clin Ther; 2008 Nov 17; 30 Pt 2():2217-27. PubMed ID: 19281916
    [Abstract] [Full Text] [Related]

  • 20. A selection-bias free method to estimate the prevalence of hypertension from an administrative primary health care database in the Girona Health Region, Spain.
    Saez M, Barceló MA, Coll de Tuero G.
    Comput Methods Programs Biomed; 2009 Mar 17; 93(3):228-40. PubMed ID: 19059668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.